Clinical Trial

Italian Multicenter Experience With Radioreceptor-assisted Therapy (PRRT)

Study acronym: PRRT-PGL-PHEO
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This multicenter retrospective Italian study evaluates the efficacy and safety of PRRT in patients with advanced, unresectable or metastatic pheochromocytomas and paragangliomas (PPGL). Data from \~210 patients treated between 2000 and 2024 will be analyzed. The primary endpoint is disease control rate (DCR). Secondary endpoints include progression-free survival (PFS), overall survival (OS), and prognostic factors.
Protocol Amendment History 1 change
notable Primary completion pushed: 2026-04-30 -> 2026-08-30 2026-07-19
Trial Details
NCT Number NCT07538791
Lead Sponsor Azienda USL Reggio Emilia - IRCCS
Conditions Pheochromocytomas, Paragangliomas
Enrollment 210 participants
Start Date 2026-08-30
Primary Completion 2026-08-30 (estimated)
Study Completion 2028-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-17